BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9020304)

  • 21. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
    Fuscoe JC
    Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
    Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
    J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers.
    Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
    Carcinogenesis; 1994 Jul; 15(7):1463-6. PubMed ID: 8033326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
    Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
    J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
    Messier TL; O'Neill JP; Hou SM; Nicklas JA; Finette BA
    EMBO J; 2003 Mar; 22(6):1381-8. PubMed ID: 12628930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex PCR analysis of in vivo-arising deletion mutations in the hprt gene of human T-lymphocytes.
    Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Moore MM
    Environ Mol Mutagen; 1994; 23(2):89-95. PubMed ID: 8143706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy.
    Keohavong P; Xi L; Day RD; Zhang L; Grant SG; Day BW; Ness RB; Bigbee WL
    Mutat Res; 2005 May; 572(1-2):156-66. PubMed ID: 15790499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
    Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
    Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens.
    Fuscoe JC; Setzer RW; Collard DD; Moore MM
    Carcinogenesis; 1996 May; 17(5):1013-20. PubMed ID: 8640906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated.
    Schlissel M; Constantinescu A; Morrow T; Baxter M; Peng A
    Genes Dev; 1993 Dec; 7(12B):2520-32. PubMed ID: 8276236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Analysis of Mutations in the Human HPRT Gene.
    Keohavong P; Xi L; Grant SG
    Methods Mol Biol; 2020; 2102():349-359. PubMed ID: 31989566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of mutations in the human HPRT gene.
    Keohavong P; Xi L; Grant SG
    Methods Mol Biol; 2014; 1105():291-301. PubMed ID: 24623237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
    Champagne DP; Shockett PE
    Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for secondary V(D)J recombination in oncogenic chromosomal translocations?
    Davila M; Foster S; Kelsoe G; Yang K
    Adv Cancer Res; 2001; 81():61-92. PubMed ID: 11430596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts.
    Morris T; Thacker J
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1392-6. PubMed ID: 8433997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of inverse PCR to amplify and sequence breakpoints of HPRT deletion and translocation mutations.
    Williams M; Rainville IR; Nicklas JA
    Environ Mol Mutagen; 2002; 39(1):22-32. PubMed ID: 11813293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of deletion mutations extending beyond the HPRT gene by multiplex PCR analysis.
    Fuscoe JC; Nelsen AJ; Pilia G
    Somat Cell Mol Genet; 1994 Jan; 20(1):39-46. PubMed ID: 8197475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. V(D)J recombinase activity in primary and secondary murine lymphoid organs: assessment by a PCR assay with extrachromosomal plasmids.
    Abe M; Hayashida K; Takayama K; Shiku H
    Int Immunol; 1991 Oct; 3(10):1025-33. PubMed ID: 1756144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria.
    Purow DB; Howard TA; Marcus SJ; Rosse WF; Ware RE
    Blood Cells Mol Dis; 1999 Apr; 25(2):81-91. PubMed ID: 10389589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.